ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood transplants made available for thousands with blood cancers
Disease control Recruiting nowThis study gives people with blood cancers, immune disorders, and other serious diseases access to cord blood transplants that are not yet FDA-approved. It includes children and adults of any age. The main goal is to see how well the new blood cells grow after transplant.
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New cord blood transplant method aims to beat High-Risk blood cancers
Disease control Recruiting nowThis study tests an improved method for cord blood transplants in adults with hard-to-treat blood cancers like leukemia and lymphoma. The approach uses a standard set of steps—including chemotherapy, radiation, and careful follow-up—to help the body accept the new stem cells. Res…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:47 UTC
-
New study follows CAR-T cells in blood cancer patients
Disease control Recruiting nowThis study looks at how well CAR-T cell therapy works for people with certain blood cancers like lymphoma and leukemia. Researchers will track the CAR-T cells in the body after infusion and measure how the disease responds. The study includes 45 patients who have not improved aft…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Last-Resort CAR-T therapy opens to patients outside clinical trials
Disease control AVAILABLEThis program provides access to tisagenlecleucel (CTL019), a CAR-T cell therapy, for people with serious blood cancers like lymphoma or leukemia who have no other treatment options and cannot join a clinical trial. Doctors must request the therapy for individual patients, and the…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for kids with returning leukemia: drug combo shows promise
Disease control Recruiting nowThis study tests whether adding the drug bortezomib to standard chemotherapy helps children and teens with high-risk relapsed acute lymphoblastic leukemia (ALL) achieve remission and live longer. About 250 participants under 18 will be randomly assigned to receive either standard…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE2 • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Early access to promising blood cancer drug for those with no other options
Disease control AVAILABLEThis program provides early access to venetoclax, a targeted therapy for several blood cancers including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and multiple myeloma. It is for people who have no other suitable treatments and cannot join a clinical trial…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Sponsor: AbbVie • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Earbud zaps insomnia in leukemia survivors: new study tests Nerve-Stimulating device
Symptom relief Recruiting nowThis study tests a small, non-invasive earbud device that gently stimulates a nerve in the ear to treat insomnia in adults who survived childhood acute lymphoblastic leukemia (ALL). About 40 survivors with moderate to severe insomnia will use the device nightly for up to 8 weeks.…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated May 26, 2026 05:47 UTC
-
Laughter yoga may ease chemo pain in kids with leukemia
Symptom relief Recruiting nowThis study tests if a gentle, home-based program of laughter and fun yoga can help lower pain in children aged 2-10 with acute lymphoblastic leukemia who are receiving chemotherapy. Sixty children will be randomly assigned to either the laughter and yoga program plus usual care, …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: NA • Sponsor: Bahaa Bou Dargham • Aim: Symptom relief
Last updated May 26, 2026 05:47 UTC
-
New study maps nerve damage in kids with leukemia to predict and prevent pain
Knowledge-focused Recruiting nowThis study follows 173 children aged 8–17 with acute lymphoblastic leukemia to understand how nerve damage from chemotherapy develops over time. Researchers will track symptoms, nutrition, mood, sleep, and activity to find patterns and predictors. The goal is to help doctors iden…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Sponsor: The Hong Kong Polytechnic University • Aim: Knowledge-focused
Last updated May 26, 2026 05:42 UTC
-
Massive study aims to uncover why cancer care fails in poorer nations
Knowledge-focused Recruiting nowThis study will look at the medical records of 18,000 children, adolescents, and young adults with cancer in low- and middle-income countries. The goal is to understand how often treatment fails or causes harmful side effects, especially for leukemia and lymphoma. The findings wi…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Sponsor: Resonance, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC